Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Olson

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Biochemistry|January 21, 2022
Biochemical Mechanisms Underlying Psychedelic-Induced NeuroplasticityDavid E Olson
ACS Pharmacology & Translational Science|April 16, 2021
The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic EffectsDavid E Olson
Journal of Experimental Neuroscience|September 29, 2018
Psychoplastogens: A Promising Class of Plasticity-Promoting NeurotherapeuticsDavid E Olson
Neuroscience Insights|August 5, 2021
Engineering Safer Psychedelics for Treating AddictionJamie Peters, David E Olson
ACS Chemical Neuroscience|July 24, 2018
Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT)Lindsay P Cameron, David E Olson
Annual Review of Physiology|November 6, 2023
The Effects of Psychedelics on Neuronal PhysiologyCassandra J Hatzipantelis, David E Olson
Journal of the American Chemical Society|August 6, 2008
Catalytic C-H amination for the preparation of substituted 1,2-diaminesDavid E Olson, J Du Bois
ACS Omega|June 8, 2018
Reaction of <i>N</i>,<i>N</i>-Dimethyltryptamine with Dichloromethane Under Common Experimental ConditionsLee E Dunlap, David E Olson
Journal of Neurochemistry|November 24, 2021
Psychedelic-inspired approaches for treating neurodegenerative disordersHannah N Saeger, David E Olson
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 24, 2023
Therapeutic mechanisms of psychedelics and entactogensBoris D Heifets, David E Olson
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Biochemistry|January 21, 2022
Biochemical Mechanisms Underlying Psychedelic-Induced NeuroplasticityDavid E Olson
ACS Pharmacology & Translational Science|April 16, 2021
The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic EffectsDavid E Olson
Journal of Experimental Neuroscience|September 29, 2018
Psychoplastogens: A Promising Class of Plasticity-Promoting NeurotherapeuticsDavid E Olson
Neuroscience Insights|August 5, 2021
Engineering Safer Psychedelics for Treating AddictionJamie Peters, David E Olson
ACS Chemical Neuroscience|July 24, 2018
Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT)Lindsay P Cameron, David E Olson
Annual Review of Physiology|November 6, 2023
The Effects of Psychedelics on Neuronal PhysiologyCassandra J Hatzipantelis, David E Olson
Journal of the American Chemical Society|August 6, 2008
Catalytic C-H amination for the preparation of substituted 1,2-diaminesDavid E Olson, J Du Bois
ACS Omega|June 8, 2018
Reaction of <i>N</i>,<i>N</i>-Dimethyltryptamine with Dichloromethane Under Common Experimental ConditionsLee E Dunlap, David E Olson
Journal of Neurochemistry|November 24, 2021
Psychedelic-inspired approaches for treating neurodegenerative disordersHannah N Saeger, David E Olson
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 24, 2023
Therapeutic mechanisms of psychedelics and entactogensBoris D Heifets, David E Olson
Pageof 8